These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

125 related items for PubMed ID: 6975658

  • 21. [Treatment of small-cell bronchogenic carcinoma with a combination of chemotherapy and irradiation (author's transl)].
    Dundalek E.
    Prax Klin Pneumol; 1980 Dec; 34(12):719-23. PubMed ID: 7465532
    [No Abstract] [Full Text] [Related]

  • 22. High-dose cyclophosphamide versus cyclophosphamide, methotrexate, 5-FU, and hydroxyurea (CMFH) in the treatment of stage III non-small cell bronchogenic carcinoma: a randomized trial.
    Pannuti F, Lelli G, Casadio M, Piana E, Di Marco AR.
    Cancer Treat Rep; 1980 Dec; 64(10-11):1131-4. PubMed ID: 7459899
    [Abstract] [Full Text] [Related]

  • 23. [Chemotherapy of bronchopulmonary cancer. Trial of the BACON protocol].
    Adenis L, Restellini J, Caty A.
    LARC Med; 1981 Nov; 1(2):50-1. PubMed ID: 6188012
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. [Trials of synchronized attack drug therapy in bronchogenic carcinoma].
    Seccia A, Scafuri L, Scognamillo A, Cocco G.
    G Ital Chemioter; 1975 Nov; 22(1-2):63-6. PubMed ID: 1235355
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Small-cell bronchogenic carcinoma--primary and relapse therapy with etoposide (VP-16), methotrexate and CCNU.
    Niederle N, Krischke W, Bremer K, Schmidt CG, Seeber S.
    Cancer Treat Rev; 1982 Jun; 9 Suppl():101-5. PubMed ID: 6290053
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Cisplatin, doxorubicin, cyclophosphamide, and vindesine combination chemotherapy for non-small cell lung cancer.
    Kelsen D, Gralla R, Stoopler M, Casper E, Cheng E, Kosloff C, Golbey R.
    Cancer Treat Rep; 1982 Feb; 66(2):247-51. PubMed ID: 7034932
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Cyclophosphamide, doxorubicin, and cisplatin in the treatment of advanced non-small cell lung cancer.
    Knost JA, Greco FA, Hande KR, Richardson RL, Fer MF, Oldham RK.
    Cancer Treat Rep; 1981 Feb; 65(11-12):941-5. PubMed ID: 7028255
    [Abstract] [Full Text] [Related]

  • 34. [Status of chemotherapy in inoperable non-small cell bronchial carcinoma].
    Brunner KW, Joss R, Goldhirsch A.
    Schweiz Rundsch Med Prax; 1983 Aug 09; 72(32):1057-62. PubMed ID: 6622423
    [No Abstract] [Full Text] [Related]

  • 35. Remission rates, survival, and prognostic factors in combination chemotherapy for bronchogenic carcinoma.
    Alberto P.
    Cancer Chemother Rep 3; 1973 Mar 09; 4(2):199-206. PubMed ID: 4729321
    [No Abstract] [Full Text] [Related]

  • 36. Methyl-CCNU, alone and in combination with vincristine, or vincristine and methotrexate, in advanced bronchogenic carcinoma.
    Richards F, Cooper MR, Muss HB, White DR, Spurr CL.
    Cancer; 1976 Sep 09; 38(3):1077-82. PubMed ID: 953956
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Combination chemotherapy (MACC) in bronchogenic carcinoma.
    Chahinian AP, Holland JF, Teirstein AS, Kirschner PA.
    Mt Sinai J Med; 1977 Sep 09; 44(6):844-5. PubMed ID: 304170
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.